In his latest column, DSN editor and chief Nigel Maynard shares how some retail pharmacies are reexamining their SKUs as healthcare services expand and supply chain constraints cause a shortage of new products.

DSN editor in chief Nigel Maynard reveals how DIR fees are seen as the most challenging issue the industry faces.

In his latest column, DSN editor and chief Nigel Maynard points to retail pharmacy’s biggest advantage in its arsenal of tools when competing with rivals.